Jefferson Fowles
Jefferson Fowles has a total of 91 co-authors. Here are the top co-authors by number of shared publications:
- Philip Weinstein
The University of Adelaide
4 shared publications - Marion A. Gray
Department of Public Health, Wellington School of Medicine and Health Sciences, University of Otago, Wellington, New Zealand
3 shared publications David Phillips
Dorset Primary Care Trust, NHS, Dorset
2 shared publicationsDinusha Fernando
Kenepuru Science Centre
2 shared publicationsGeorge V. Alexeeff
Office of Environmental Health Hazard Assessment, California Environmental Protection Agency, 1515 Clay Street, Oakland, CA 94612, USA
2 shared publicationsMarcy I. Banton
LyondellBasell, Houston, TX 77010, USA
2 shared publications
Latest Publications
- 14 August 2024
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 152, 105684
Prenatal developmental toxicity studies of allyl alcohol in rats and rabbits
- 14 August 2024
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 152, 105684
Prenatal developmental toxicity studies of allyl alcohol in rats and rabbits
- 1 October 2020
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 202 (8) , 1187-1189
Potential of Ethenone (Ketene) to Contribute to Electronic Cigarette, or Vaping, Product Use–associated Lung Injury
- 1 October 2020
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 202 (8) , 1187-1189
Potential of Ethenone (Ketene) to Contribute to Electronic Cigarette, or Vaping, Product Use–associated Lung Injury
- Open Access
- 25 January 2018
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 15 (2) , 200
Analysis and Assessment of Exposure to Selected Phthalates Found in Children’s Toys in Christchurch, New Zealand
Internationally several phthalates are subject to regulatory control regarding maximum allowable concentrations in children’s toys. Such regulation is not in place in New Zealand. Phthalates have been associated with developmental toxicity and endocrine disruption. We determined the concentration of seven phthalates in children’s toys purchased in Christchurch, New Zealand. These results provided data for an exposure assessment deriving Hazard Indices (HI) for oral and dermal exposure routes in children, based on the concentration of mixtures of phthalates shown by the EU to produce either reproductive/developmental or hepatotoxic effects. Of the 49 toys analyzed, 65% contained at least one phthalate at a concentration of >0.1% by mass; and 35% contained multiple-phthalates at individual concentrations of >0.1%. A HI of 3.4 was derived for the combined exposures to the four phthalates associated with reproductive and developmental effects. A HI of 0.3 was derived for the group of phthalates associated with hepatotoxic effects. Five phthalates were detected at levels exceeding the EU regulatory limit of 0.1% by mass. Risk assessment calculations indicate that, using realistic exposure scenarios, the worst-case combined exposure to phthalates associated with developmental toxicity exceeded a HI of 1 so may cause adverse developmental effects.
- 25 January 2018
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 15 (2) , 200
Open AccessAnalysis and Assessment of Exposure to Selected Phthalates Found in Children’s Toys in Christchurch, New Zealand
Internationally several phthalates are subject to regulatory control regarding maximum allowable concentrations in children’s toys. Such regulation is not in place in New Zealand. Phthalates have been associated with developmental toxicity and endocrine disruption. We determined the concentration of seven phthalates in children’s toys purchased in Christchurch, New Zealand. These results provided data for an exposure assessment deriving Hazard Indices (HI) for oral and dermal exposure routes in children, based on the concentration of mixtures of phthalates shown by the EU to produce either reproductive/developmental or hepatotoxic effects. Of the 49 toys analyzed, 65% contained at least one phthalate at a concentration of >0.1% by mass; and 35% contained multiple-phthalates at individual concentrations of >0.1%. A HI of 3.4 was derived for the combined exposures to the four phthalates associated with reproductive and developmental effects. A HI of 0.3 was derived for the group of phthalates associated with hepatotoxic effects. Five phthalates were detected at levels exceeding the EU regulatory limit of 0.1% by mass. Risk assessment calculations indicate that, using realistic exposure scenarios, the worst-case combined exposure to phthalates associated with developmental toxicity exceeded a HI of 1 so may cause adverse developmental effects.
- Open Access
- 1 December 2017
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 91, 240-248
Studies on the environmental fate, ecotoxicology and toxicology of 2-methyl 1,3-propanediol
- 1 December 2017
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 91, 240-248
Open AccessStudies on the environmental fate, ecotoxicology and toxicology of 2-methyl 1,3-propanediol
- Open Access
- 1 August 2017
- Published by Elsevier in Toxicology Letters
- Vol. 278, 66-83
A toxicological review of the ethylene glycol series: Commonalities and differences in toxicity and modes of action
- 1 August 2017
- Published by Elsevier in Toxicology Letters
- Vol. 278, 66-83
Open AccessA toxicological review of the ethylene glycol series: Commonalities and differences in toxicity and modes of action
- Open Access
- 1 July 2016
- Published by Elsevier in Toxicology Letters
- Vol. 254, 52-62
Assessment of petroleum streams for thyroid toxicity
- 1 July 2016
- Published by Elsevier in Toxicology Letters
- Vol. 254, 52-62
Open AccessAssessment of petroleum streams for thyroid toxicity
- Open Access
- 21 July 2015
- Published by Springer Nature in International Archives of Occupational and Environmental Health
- Vol. 89 (2) , 307-318
Serum concentrations of chlorinated dibenzo-p-dioxins, furans and PCBs, among former phenoxy herbicide production workers and firefighters in New Zealand
To quantify serum concentrations of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and dioxin-like compounds in former phenoxy herbicide production plant workers and firefighters, 20 years after 2,4,5-T production ceased. Of 1025 workers employed any time during 1969–1984, 430 were randomly selected and invited to take part in a morbidity survey and provide a blood sample; 244 (57 %) participated. Firefighters stationed in close proximity of the plant and/or engaged in call-outs to the plant between 1962 and 1987 also participated (39 of 70 invited). Reported here are the serum concentrations of TCDD and other chlorinated dibenzo-dioxins, dibenzofurans, and polychlorinated biphenyls (PCBs). Determinants of the serum concentrations were assessed using linear regression. The 60 men who had worked in the phenoxy/TCP production area had a mean TCDD serum concentration of 19.1 pg/g lipid, three times the mean concentration of the 141 men and 43 women employed in other parts of the plant (6.3 and 6.0 pg/g respectively), and more than 10 times the mean for the firefighters (1.6 pg/g). Duration of employment in phenoxy herbicide synthesis, maintenance work, and work as a boilerman, chemist, and packer were associated with increased serum concentrations of TCDD and 1,2,3,4,7-pentachlorodibenzo-p-dioxin (PeCDD). Employment as a boilerman was also associated with elevated serum concentrations of PCBs. Occupations in the plant associated with phenoxy herbicide synthesis had elevated levels of TCDD and PeCDD. Most other people working within the plant, and the local firefighters, had serum concentrations of dioxin-like compounds comparable to those of the general population.
- 21 July 2015
- Published by Springer Nature in International Archives of Occupational and Environmental Health
- Vol. 89 (2) , 307-318
Open AccessSerum concentrations of chlorinated dibenzo-p-dioxins, furans and PCBs, among former phenoxy herbicide production workers and firefighters in New Zealand
To quantify serum concentrations of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and dioxin-like compounds in former phenoxy herbicide production plant workers and firefighters, 20 years after 2,4,5-T production ceased. Of 1025 workers employed any time during 1969–1984, 430 were randomly selected and invited to take part in a morbidity survey and provide a blood sample; 244 (57 %) participated. Firefighters stationed in close proximity of the plant and/or engaged in call-outs to the plant between 1962 and 1987 also participated (39 of 70 invited). Reported here are the serum concentrations of TCDD and other chlorinated dibenzo-dioxins, dibenzofurans, and polychlorinated biphenyls (PCBs). Determinants of the serum concentrations were assessed using linear regression. The 60 men who had worked in the phenoxy/TCP production area had a mean TCDD serum concentration of 19.1 pg/g lipid, three times the mean concentration of the 141 men and 43 women employed in other parts of the plant (6.3 and 6.0 pg/g respectively), and more than 10 times the mean for the firefighters (1.6 pg/g). Duration of employment in phenoxy herbicide synthesis, maintenance work, and work as a boilerman, chemist, and packer were associated with increased serum concentrations of TCDD and 1,2,3,4,7-pentachlorodibenzo-p-dioxin (PeCDD). Employment as a boilerman was also associated with elevated serum concentrations of PCBs. Occupations in the plant associated with phenoxy herbicide synthesis had elevated levels of TCDD and PeCDD. Most other people working within the plant, and the local firefighters, had serum concentrations of dioxin-like compounds comparable to those of the general population.
- 12 March 2013
- Published by Taylor & Francis in Critical Reviews in Toxicology
- Vol. 43 (4) , 363-390
A toxicological review of the propylene glycols
The toxicological profiles of monopropylene glycol (MPG), dipropylene glycol (DPG), tripropylene glycol (TPG) and polypropylene glycols (PPG; including tetra-rich oligomers) are collectively reviewed, and assessed considering regulatory toxicology endpoints. The review confirms a rich data set for these compounds, covering all of the major toxicological endpoints of interest. The metabolism of these compounds share common pathways, and a consistent profile of toxicity is observed. The common metabolism provides scientific justification for adopting a read-across approach to describing expected hazard potential from data gaps that may exist for specific oligomers. None of the glycols reviewed presented evidence of carcinogenic, mutagenic or reproductive/developmental toxicity potential to humans. The pathologies reported in some animal studies either occurred at doses that exceeded experimental guidelines, or involved mechanisms that are likely irrelevant to human physiology and therefore are not pertinent to the exposures experienced by consumers or workers. At very high chronic doses, MPG causes a transient, slight decrease in hemoglobin in dogs and at somewhat lower doses causes Heinz bodies to form in cats in the absence of any clinical signs of anemia. Some evidence for rare, idiosyncratic skin reactions exists for MPG. However, the larger data set indicates that these compounds have low sensitization potential in animal studies, and therefore are unlikely to represent human allergens. The existing safety evaluations of the FDA, USEPA, NTP and ATSDR for these compounds are consistent and point to the conclusion that the propylene glycols present a very low risk to human health.
- 12 March 2013
- Published by Taylor & Francis in Critical Reviews in Toxicology
- Vol. 43 (4) , 363-390
A toxicological review of the propylene glycols
The toxicological profiles of monopropylene glycol (MPG), dipropylene glycol (DPG), tripropylene glycol (TPG) and polypropylene glycols (PPG; including tetra-rich oligomers) are collectively reviewed, and assessed considering regulatory toxicology endpoints. The review confirms a rich data set for these compounds, covering all of the major toxicological endpoints of interest. The metabolism of these compounds share common pathways, and a consistent profile of toxicity is observed. The common metabolism provides scientific justification for adopting a read-across approach to describing expected hazard potential from data gaps that may exist for specific oligomers. None of the glycols reviewed presented evidence of carcinogenic, mutagenic or reproductive/developmental toxicity potential to humans. The pathologies reported in some animal studies either occurred at doses that exceeded experimental guidelines, or involved mechanisms that are likely irrelevant to human physiology and therefore are not pertinent to the exposures experienced by consumers or workers. At very high chronic doses, MPG causes a transient, slight decrease in hemoglobin in dogs and at somewhat lower doses causes Heinz bodies to form in cats in the absence of any clinical signs of anemia. Some evidence for rare, idiosyncratic skin reactions exists for MPG. However, the larger data set indicates that these compounds have low sensitization potential in animal studies, and therefore are unlikely to represent human allergens. The existing safety evaluations of the FDA, USEPA, NTP and ATSDR for these compounds are consistent and point to the conclusion that the propylene glycols present a very low risk to human health.
- 1 December 2012
- Published by Springer Nature
- p. 549-567
Environmental Medicine
- 20 March 2012
- Published by Taylor & Francis in Inhalation Toxicology
- Vol. 24 (4) , 213-226
Acute inhalation study of allyl alcohol for derivation of acute exposure guideline levels
An acute, whole-body inhalation study for allyl alcohol in Sprague-Dawley rats was designed to support derivation of AEGL values, with emphasis on establishing NOAELs for irreversible effects of different exposure concentrations and durations. Groups of 10 rats were exposed for 1 hour (0, 50, 200, or 400 ppm), 4 hours (0, 20, 50, or 100 ppm), or 8 hours (0, 10, 20, or 50 ppm). Clinical evaluations were performed during exposure and in an open field within 22–71 minutes after termination of exposure. Clinical pathology, gross necropsy, and histopathology (nasal tissues, larynx, trachea, lungs/bronchi, liver, and kidneys) were evaluated 14 days after exposure. Mortality was limited to 1 male exposed for 8 hours to 50 ppm. Clinical findings of gasping, rales, increased respiration noted at higher exposure levels were rapidly reversed. No treatment-related findings were observed in the liver and kidneys, or in the lungs of surviving animals. Histopathology in the nasal cavity was noted at all exposure levels following 1, 4, or 8 hours of exposure. Mild nasal inflammation was found at the lowest exposure levels (50-ppm/1-hour, 20-ppm/4-hour, and 10-ppm/8-hour). These effects were considered reversible and were not associated with related clinical signs. Severe, irreversible nasal olfactory epithelial lesions were present in 50 ppm/8-hour males. The NOELs for irreversible effects were 400-ppm/1-hour, 100-ppm/4-hour, and 20-ppm/8-hour. The incidence of severe findings was positively dependent on both concentration and the exposure duration. In contrast, the incidence of mild reversible findings did not appear to be dependent on duration.
- 20 March 2012
- Published by Taylor & Francis in Inhalation Toxicology
- Vol. 24 (4) , 213-226
Acute inhalation study of allyl alcohol for derivation of acute exposure guideline levels
An acute, whole-body inhalation study for allyl alcohol in Sprague-Dawley rats was designed to support derivation of AEGL values, with emphasis on establishing NOAELs for irreversible effects of different exposure concentrations and durations. Groups of 10 rats were exposed for 1 hour (0, 50, 200, or 400 ppm), 4 hours (0, 20, 50, or 100 ppm), or 8 hours (0, 10, 20, or 50 ppm). Clinical evaluations were performed during exposure and in an open field within 22–71 minutes after termination of exposure. Clinical pathology, gross necropsy, and histopathology (nasal tissues, larynx, trachea, lungs/bronchi, liver, and kidneys) were evaluated 14 days after exposure. Mortality was limited to 1 male exposed for 8 hours to 50 ppm. Clinical findings of gasping, rales, increased respiration noted at higher exposure levels were rapidly reversed. No treatment-related findings were observed in the liver and kidneys, or in the lungs of surviving animals. Histopathology in the nasal cavity was noted at all exposure levels following 1, 4, or 8 hours of exposure. Mild nasal inflammation was found at the lowest exposure levels (50-ppm/1-hour, 20-ppm/4-hour, and 10-ppm/8-hour). These effects were considered reversible and were not associated with related clinical signs. Severe, irreversible nasal olfactory epithelial lesions were present in 50 ppm/8-hour males. The NOELs for irreversible effects were 400-ppm/1-hour, 100-ppm/4-hour, and 20-ppm/8-hour. The incidence of severe findings was positively dependent on both concentration and the exposure duration. In contrast, the incidence of mild reversible findings did not appear to be dependent on duration.